uniQure N.V (NASDAQ: QURE) kicked off on Friday, up 3.40% from the previous trading day, before settling in for the closing price of $13.25. Over the past 52 weeks, QURE has traded in a range of $3.73-$19.18.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 323.68% over the last five years. While this was happening, its average annual earnings per share was recorded 29.11%. With a float of $49.67 million, this company’s outstanding shares have now reached $54.70 million.
The firm has a total of 209 workers. Let’s measure their productivity. In terms of profitability, gross margin is 40.76%, operating margin of -855.32%, and the pretax margin is -1065.82%.
uniQure N.V (QURE) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of uniQure N.V is 8.47%, while institutional ownership is 89.66%. The most recent insider transaction that took place on Mar 04 ’25, was worth 291,629. In this transaction CEO, Managing Director of this company sold 28,341 shares at a rate of $10.29, taking the stock ownership to the 651,454 shares. Before that another transaction happened on Mar 04 ’25, when Company’s Chief Medical Officer sold 1,350 for $10.29, making the entire transaction worth $13,891. This insider now owns 151,903 shares in total.
uniQure N.V (QURE) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 29.11% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.73% during the next five years compared to -9.66% drop over the previous five years of trading.
uniQure N.V (NASDAQ: QURE) Trading Performance Indicators
Take a look at uniQure N.V’s (QURE) current performance indicators. Last quarter, stock had a quick ratio of 11.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 37.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.39, a number that is poised to hit -0.89 in the next quarter and is forecasted to reach -3.03 in one year’s time.
Technical Analysis of uniQure N.V (QURE)
Analysing the last 5-days average volume posted by the [uniQure N.V, QURE], we can find that recorded value of 1.49 million was lower than the volume posted last year of 1.51 million. As of the previous 9 days, the stock’s Stochastic %D was 51.92%. Additionally, its Average True Range was 1.34.
During the past 100 days, uniQure N.V’s (QURE) raw stochastic average was set at 52.01%, which indicates a significant decrease from 59.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 179.24% in the past 14 days, which was higher than the 117.99% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.43, while its 200-day Moving Average is $10.26. Now, the first resistance to watch is $14.20. This is followed by the second major resistance level at $14.69. The third major resistance level sits at $15.19. If the price goes on to break the first support level at $13.20, it is likely to go to the next support level at $12.70. Should the price break the second support level, the third support level stands at $12.21.
uniQure N.V (NASDAQ: QURE) Key Stats
The company with the Market Capitalisation of 750.05 million has total of 54,776K Shares Outstanding. Its annual sales at the moment are 27,120 K in contrast with the sum of -239,560 K annual income. Company’s last quarter sales were recorded 1,570 K and last quarter income was -43,640 K.
